S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
ASX:CDT

Castle Minerals (CDT) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free CDT Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
9.79%
Price Target
N/A
Stock Analysis
Stock Analysis
CDT stock logo

About Castle Minerals Stock (ASX:CDT)

Castle Minerals Limited engages in the exploration of gold, graphite, and other mineral deposits in West Africa and Australia. The company explores for lithium, graphite, gold, and base and battery metals. Its flagship project is the 100% owned Kambale graphite project located in Ghana, West Africa. The company also holds 100% interests in Meekatharra projects, Earaheedy basin project, Great Southern project, and Woodcutters project, as well as 80% interest in Pilbara projects located in Western Australia. In addition, it holds interests in the Carlie mining gold projects located in Ghana, West Africa. Castle Minerals Limited was incorporated in 2005 and is based in West Perth, Australia.

CDT Stock News Headlines

February 4, 2024 | msn.com
Top 10 at 10: Legal mushrooms? The party is at Bioxyne’s house
November 3, 2023 | finance.yahoo.com
Here's Why Shareholders May Want To Be Cautious With Increasing Castle Minerals Limited's (ASX:CDT) CEO Pay Packet
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
October 22, 2023 | msn.com
Resources Top 5: Wildcat digs up another thick lithium find; China’s shock export ban surges local graphite stocks
September 23, 2023 | finance.yahoo.com
Castle Minerals Full Year 2023 Earnings: AU$0.005 loss per share (vs AU$0.002 loss in FY 2022)
September 21, 2023 | msn.com
Resources Top 5: For their first investment, this Hong Kong group sunk $10m into a NSW gold junior worth… $7m
May 9, 2023 | benzinga.com
Castle Analytics LLC Announces Launch of Digital Index Fund
March 28, 2023 | barrons.com
Castle Minerals Ltd.
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 10, 2023 | bizjournals.com
40 Under 40
October 9, 2022 | reuters.com
CDT.AX - | Stock Price & Latest News | Reuters
September 7, 2022 | technews.tmcnet.com
MINELAB JOINS DETECTIVAL 2022
May 19, 2022 | proactiveinvestors.com
SensOre wraps up drilling at Eaglehawk gold target of Tea Well joint venture in WA
January 4, 2022 | finance.yahoo.com
We Think Castle Minerals (ASX:CDT) Needs To Drive Business Growth Carefully
November 10, 2021 | msn.com
The Castle Minerals (ASX:CDT) share price has surged 78% in a week. Here’s why
August 26, 2021 | stockhouse.com
NRP Stone Subsidiary Announces Launch Date on Blue Origin New Shepard Rocket
July 24, 2021 | au.finance.yahoo.com
Castle Minerals Limited (CDT.AX)
July 24, 2021 | investing.com
Castle Minerals Ltd (CDT)
See More Headlines
Receive CDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Castle Minerals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Basic Materials
Industry
Gold
Sub-Industry
N/A
Current Symbol
ASX:CDT
CUSIP
N/A
CIK
N/A
Web
www.castleminerals.com
Phone
61 8 9322 7018
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,680,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-269.77%
Return on Assets
-146.88%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
3.60
Quick Ratio
21.60

Sales & Book Value

Annual Sales
$409.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,220,000,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.89
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (ASX:CDT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media